167 related articles for article (PubMed ID: 38610011)
21. Soy-Based Infant Formula Feeding and Uterine Fibroid Development in a Prospective Ultrasound Study of Black/African-American Women.
Langton CR; Harmon QE; Upson K; Baird DD
Environ Health Perspect; 2023 Jan; 131(1):17006. PubMed ID: 36696103
[TBL] [Abstract][Full Text] [Related]
22. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
[TBL] [Abstract][Full Text] [Related]
23. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
[TBL] [Abstract][Full Text] [Related]
24. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women.
Zimmermann A; Bernuit D; Gerlinger C; Schaefers M; Geppert K
BMC Womens Health; 2012 Mar; 12():6. PubMed ID: 22448610
[TBL] [Abstract][Full Text] [Related]
25. Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions.
Riggan KA; Stewart EA; Balls-Berry JE; Venable S; Allyse MA
J Patient Exp; 2021; 8():23743735211049655. PubMed ID: 34692992
[TBL] [Abstract][Full Text] [Related]
26. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
[TBL] [Abstract][Full Text] [Related]
27. Uterine fibroids and risk of hypertensive disorders of pregnancy - results from a racially diverse high-risk cohort.
Cameron K; Borahay M; Hong X; Baker V; Vaught A; Wang X
medRxiv; 2024 Mar; ():. PubMed ID: 38496516
[TBL] [Abstract][Full Text] [Related]
28. Douching or Perineal Talc Use and Prevalent Fibroids in Young African American Women.
Wright MA; Moore KR; Upson K; Baird DD; Chin HB
J Womens Health (Larchmt); 2021 Dec; 30(12):1729-1735. PubMed ID: 33667128
[No Abstract] [Full Text] [Related]
29. Uterine fibroids--do size and location determine menstrual blood loss?
Sulaiman S; Khaund A; McMillan N; Moss J; Lumsden MA
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):85-9. PubMed ID: 15223171
[TBL] [Abstract][Full Text] [Related]
30. Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
Al-Hendy A; Bradley L; Owens CD; Wang H; Barnhart KT; Feinberg E; Schlaff WD; Puscheck EE; Wang A; Gillispie V; Hurtado S; Muneyyirci-Delale O; Archer DF; Carr BR; Simon JA; Stewart EA
Am J Obstet Gynecol; 2021 Jan; 224(1):72.e1-72.e50. PubMed ID: 32702363
[TBL] [Abstract][Full Text] [Related]
31. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
[TBL] [Abstract][Full Text] [Related]
32. Racial disparities in uterine fibroids and endometriosis: a systematic review and application of social, structural, and political context.
Katon JG; Plowden TC; Marsh EE
Fertil Steril; 2023 Mar; 119(3):355-363. PubMed ID: 36682686
[TBL] [Abstract][Full Text] [Related]
33. "I Wasn't Presented With Options": Perspectives of Black Veterans Receiving Care for Uterine Fibroids in the Veterans Health Administration.
Carey C; Silvestrini M; Callegari LS; Katon JG; Bossick AS; Doll KM; Christy A; Washington DL; Owens S
Womens Health Issues; 2023; 33(6):652-660. PubMed ID: 37689493
[TBL] [Abstract][Full Text] [Related]
34. Evidence that geographic variation in genetic ancestry associates with uterine fibroids.
Keaton JM; Jasper EA; Hellwege JN; Jones SH; Torstenson ES; Edwards TL; Velez Edwards DR
Hum Genet; 2021 Oct; 140(10):1433-1440. PubMed ID: 34302236
[TBL] [Abstract][Full Text] [Related]
35. Incidence and health care burden of uterine fibroids among female service members in the active component of the U.S. Armed Forces, 2011-2022.
Nieh C; Mabila SL
MSMR; 2024 Feb; 31(2):9-15. PubMed ID: 38466970
[TBL] [Abstract][Full Text] [Related]
36. Soy-Based Infant Formula Feeding and Ultrasound-Detected Uterine Fibroids among Young African-American Women with No Prior Clinical Diagnosis of Fibroids.
Upson K; Harmon QE; Baird DD
Environ Health Perspect; 2016 Jun; 124(6):769-75. PubMed ID: 26565393
[TBL] [Abstract][Full Text] [Related]
37. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
38. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Sangkomkamhang US; Lumbiganon P; Laopaiboon M; Mol BW
Cochrane Database Syst Rev; 2013 Feb; (2):CD008994. PubMed ID: 23450594
[TBL] [Abstract][Full Text] [Related]
39. Association between uterine fibroids and antimüllerian hormone concentrations among African American women.
Bernardi LA; Waldo A; Berrocal VJ; Wise LA; Marsh EE
Fertil Steril; 2022 Apr; 117(4):832-840. PubMed ID: 35105447
[TBL] [Abstract][Full Text] [Related]
40. Complementary and Alternative Medicine Use Among Women with Symptomatic Uterine Fibroids.
Rubio EM; Hilton JF; Bent S; Parvataneni R; Oberman E; Saberi NS; Varon S; Schembri M; Waetjen LE; Jacoby VL
J Womens Health (Larchmt); 2023 May; 32(5):546-552. PubMed ID: 37023398
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
